Inicio › Leucemia linfoblástica aguda › Nueva York
Ensayos clínicos de Leucemia linfoblástica aguda en Nueva York
32 estudios sobre Leucemia linfoblástica aguda buscan participantes en Nueva York.
Ciudades en Nueva York
- New York City24 estudios
- Queens6 estudios
- The Bronx5 estudios
- Rochester4 estudios
- Buffalo4 estudios
- Greenburgh4 estudios
- New Rochelle3 estudios
- Staten Island3 estudios
Texto oficial del estudio (inglés)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 12 a 78 · Todos los sexos · Actualizado el 29 sept 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
ReclutandoFase 2
6 Months · Todos los sexos · Actualizado el 28 sept 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Columbia University Medical Center, New York
ReclutandoEstudio observacional
4 Weeks – 18 Years · Todos los sexos · Actualizado el 24 sept 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 23 sept 2026 · NCT06308588A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
ReclutandoFase 1/2
30 Days · Todos los sexos · Actualizado el 16 sept 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
ReclutandoFase 1
Edades de 0 a 18 · Todos los sexos · Actualizado el 16 sept 2026 · NCT06173518Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 2
Edades de 21 a 65 · Todos los sexos · Actualizado el 11 sept 2026 · NCT05884333First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 1 sept 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- y 7 más
ReclutandoFase 1/2
Hasta los 22 · Todos los sexos · Actualizado el 25 ago 2026 · NCT04726241A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 20 ago 2026 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
ReclutandoFase 1/2
Edades de 1 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07070219MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Roswell Park Cancer Institute, Buffalo
ReclutandoSe aceptan voluntarios sanos
Todas las edades · Todos los sexos · Actualizado el 12 ago 2026 · NCT06323044Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
ReclutandoFase 1/2
Edades de 16 en adelante · Todos los sexos · Actualizado el 20 jul 2026 · NCT07155226A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- y 9 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 6 jul 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 22 jun 2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1/2
Hasta los 1 · Todos los sexos · Actualizado el 3 jun 2026 · NCT05848687European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
ReclutandoEstudio observacional
Edades de 3 a 21 · Todos los sexos · Actualizado el 2 jun 2026 · NCT05375617Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- y 1 más
ReclutandoEstudio observacional
Todas las edades · Todos los sexos · Actualizado el 18 may 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
ReclutandoFase 2
Hasta los 26 · Todos los sexos · Actualizado el 14 may 2026 · NCT07566377A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1160, Stony Brook
- Ascentage Investigative Site #1151, The Bronx
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 30 abr 2026 · NCT06051409Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Reclutando
Edades de 3 a 9 · Todos los sexos · Actualizado el 23 abr 2026 · NCT06074666Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- The Mt. Hope Family Center, Rochester
Reclutando
Edades de 8 a 17 · Todos los sexos · Actualizado el 8 abr 2026 · NCT06956781A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
ReclutandoFase 1/2
Edades de 12 en adelante · Todos los sexos · Actualizado el 24 mar 2026 · NCT04988555A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
- University of Rochester Medical Center, Wilmot Cancer Center, Rochester
ReclutandoFase 1/2
Edades de 18 en adelante · Todos los sexos · Actualizado el 18 mar 2026 · NCT06207123A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
ReclutandoFase 2
Edades de 18 a 66 · Todos los sexos · Actualizado el 17 mar 2026 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 2
Edades de 18 a 54 · Todos los sexos · Actualizado el 17 mar 2026 · NCT06918431A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- y 1 más
ReclutandoFase 1
Edades de 17 en adelante · Todos los sexos · Actualizado el 10 feb 2026 · NCT06287528Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 12 en adelante · Todos los sexos · Actualizado el 8 ene 2026 · NCT04872478A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Columbia University Medical Center, New York
Reclutando
Edades de 5 a 21 · Todos los sexos · Actualizado el 7 oct 2025 · NCT05963971Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 15 abr 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
ReclutandoFase 1
Edades de 1 a 21 · Todos los sexos · Actualizado el 6 dic 2024 · NCT05476770De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.